Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 11/20 | 0.55 |
| ▸ | TSHR | P16473 | 11/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 10/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 10/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 12/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6407056 | 0.86 | CA1 (0.45) | TSHRALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL6409515 | 0.85 | CYP1A2 (0.39) | CYP3A4TSHRCYP1A2CYP2D6HSD17B10 | |
| SCHEMBL6409587 | 0.84 | FFAR4 (0.49) | CYP1A2ALDH1A1SLC6A4SLC6A3 | |
| SCHEMBL6409506 | 0.80 | FABP7 (0.44) | MEN1KMT2A | |
| SCHEMBL13323626 | 0.76 | CYP1A2 (0.38) | CYP3A4TSHRCYP1A2CYP2D6HSD17B10 | |
| SCHEMBL6408121 | 0.76 | CHRNA7 (0.35) | — | |
| SCHEMBL6406514 | 0.75 | SLC6A4 (0.43) | CYP3A4TSHRCYP1A2CYP2D6HSD17B10 | |
| SCHEMBL6411935 | 0.75 | ALDH1A1 (0.50) | TSHRCYP1A2CYP2D6MAPK1CYP2C19 | |
| SCHEMBL17407791 | 0.75 | CPB1 (0.51) | CYP3A4TSHRCYP1A2CYP2D6HSD17B10 | |
| SCHEMBL6407549 | 0.75 | CPB1 (0.51) | CYP3A4TSHRCYP1A2CYP2D6HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288526-A1 | Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids | SUMITOMO CHEMICAL COMPAY LIMTED (JP) | 2005-12-29 | — | — | US | disclosed |
| EP-1538141-A1 | PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS | Sumitomo Chemical Company, Limited (JP) | 2005-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288526-A1 | Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids | GRHPR, PCCA, C5 | CYP3A4 240/4885TSHR 1466/4885CYP1A2 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.